A M Chiarelli
Affiliation: Cancer Care Ontario
- False-positive result and reattendance in the Ontario Breast Screening ProgramA M Chiarelli
Cancer Care Ontario, Department of Public Health Sciences, University of Toronto, Canada
J Med Screen 10:129-33. 2003..To determine the association between initial screen result and returning for a second screen in an organised breast screening programme for women with a biennial screening recommendation...
- Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detectionAnna M Chiarelli
Division of Preventive Oncology, Cancer Care Ontario, 620 University Avenue, Toronto, Ontario, Canada M5G 2L7
Cancer Epidemiol Biomarkers Prev 15:1856-62. 2006..This study explores this relationship further by examining the influence of patterns of HRT use and the percentage of mammographic density on the detection of breast cancer by classification of interval cancer...
- Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening ProgramAnna M Chiarelli
Division of Preventive Oncology, Cancer Care Ontario, Toronto
Can J Public Health 96:259-63. 2005..This study will examine delays to assessment and diagnosis for women with an abnormal mammogram compared to women with an abnormal clinical breast examination (CBE) or abnormal CBE and mammogram...
- Socioeconomic status & returning for a second screen in the Ontario breast screening programR K Tatla
Toronto Sunnybrook Regional Cancer Centre, Cancer Care Ontario, Canada
Breast 12:237-46. 2003..Low SES women, particularly in urban areas, should be specifically targeted to increase their likelihood of re-attendance for breast cancer screening within an organized program...
- Breast screening outcomes in women with and without a family history of breast and/or ovarian cancerE E Halapy
Division of Preventive Oncology, Cancer Care Ontario, 620 University Avenue, Toronto, ON M5G 2L7, Canada
J Med Screen 11:32-8. 2004..To compare breast screening outcomes between women with a moderate or strong family history of breast and/or ovarian cancer with those without such a history...
- Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancerNorman F Boyd
Ontario Cancer Institute, Room 10 415, 610 University Avenue, Toronto, Ontario, Canada M5G 2K9
Cancer Epidemiol Biomarkers Prev 15:961-6. 2006..This research was undertaken to determine whether the effect of hormone therapy on breast cancer risk is mediated by its effect on mammographic density...
- The heritability of mammographically dense and nondense breast tissueJennifer Stone
Centre for Molecular Environmental Genetic and Analytic Epidemiology, The University of Melbourne, Carlton, Victoria, Australia
Cancer Epidemiol Biomarkers Prev 15:612-7. 2006..Our previous twin study showed that the heritability of PMD was 63%. This study determined the heritabilities of the components of PMD, the areas of dense and nondense tissue in the mammogram...
- Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000Anna M Chiarelli
Division of Preventive Oncology, Cancer Care Ontario, Toronto, Canada
Eur J Cancer Prev 15:34-42. 2006..Although some enhancements of the programme are necessary, the OBSP met or exceeded Canadian targets for most performance measures...
- Accuracy of breast screening among women with and without a family history of breast and/or ovarian cancerErika Halapy
Division of Preventive Oncology, Cancer Care Ontario, 620 University Avenue, Toronto, Ontario M5G 2L7, Canada
Breast Cancer Res Treat 90:299-305. 2005..To compare interval cancer rates, sensitivity and specificity of breast cancer screening between women with moderate or strong family history and women without a family history...
- Influence of physician and patient characteristics on adherence to breast cancer screening recommendationsNada Abdel-Malek
Division of Preventive Oncology, Cancer Care Ontario, Canada
Eur J Cancer Prev 17:48-53. 2008..7). A low proportion of Ontario physicians adhere to recommended breast screening guidelines. Future research into effective strategies to increase adherence should take into account practice location, setting and patient characteristics...